Atlas FDA

VITEK(R) 2 GRAM POSITIVE AST FOR TRIMETHOPRIM/SULFAMETHOXAZOLE

FDA premarket approval N50510/S139 · decided 2000-06-26

Approval details

PMA number
N50510
Supplement
S139
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
VITEK(R) 2 GRAM POSITIVE AST FOR TRIMETHOPRIM/SULFAMETHOXAZOLE
Generic name
Susceptibility test cards, antimicrobial
Applicant
Biomerieux Vitek, Inc.
Date received
2000-04-12
Decision date
2000-06-26
Days to decision
75 days
Decision code
APPR
Product code
LTW
Advisory committee
Microbiology
Expedited review
No
Location
Hazelwood, MO
Statement
APPROVAL FOR THE ADDITION OF THE ANTIBIOTIC TRIMETHOPRIM/SULFAMETHOXAZOLE AT CONCENTRATIONS OF 2/38, 8/152, 16/304 AND 32/608 MICROGRAMS/ML TO THE VITEK(R) 2 S. PNEUMONIAE SUSCEPTIBILITY TEST SYSTEM. THE DEVICE AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME VITEK(R) 2 S. PNEUMONIAE SUSCEPTIBILITY TEST CARDS FOR USE IN THE VITEK(R) 2 SYSTEM AND IS INDICATED FOR USE FOR THE SUSCEPTIBILITY TESTING OF STREPTOCOCCUS PNEUMONIAE TO TRIMETHOPRIM/SULFAMETHOXAZOLE IN THE RANGE OF <=0.5/9.5 TO >=16/304

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
VIDAS D-DIMER (DD) ASSAY (K973819)Biomerieux Vitek, Inc.1998-03-10
VIDAS ROTAVIRUS (RTV) ASSAY (K972895)Biomerieux Vitek, Inc.1997-10-03
VIDAS ROTAVIRUS ASSAY (K965092)Biomerieux Vitek, Inc.1997-05-05
VIDAS C. DIFFICILE TOXIN A II ASSAY (K964887)Biomerieux Vitek, Inc.1997-04-08
VIDAS CHLAMYDIA BLOCKING ASSAY (K955627)Biomerieux Vitek, Inc.1996-10-07
VIDAS CREATINE KINASE MB ASSAY 30-421 (K962549)Biomerieux Vitek, Inc.1996-08-30
GRAM NEGATIVE IDENTIFICATION PLUS CARD (K962609)Biomerieux Vitek, Inc.1996-08-30
VITEK GRAM POSITIVE IDENTIFICATION CARD (GPI) (K952095)Biomerieux Vitek, Inc.1996-03-12